<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940602-2-00077</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Centers for Disease Control and Prevention</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> Advisory Committee on Immunization Practices; Meeting <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92&hyph;463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting: <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Name: Advisory Committee on Immunization Practices. <!-- PJG 0012 frnewline --> Times and Dates: 8:30 a.m.&hyph;5 p.m., June 29, 1994; 8:30 a.m.&hyph;12:45 p.m., June 30, 1994. <!-- PJG 0012 frnewline --> Place: CDC, Auditorium A, Building 2, 1600 Clifton Road, NE, Atlanta, Georgia 30333. <!-- PJG 0012 frnewline --> Status: Open to the public, limited only by the space available. <!-- PJG 0012 frnewline --> Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. <!-- PJG 0012 frnewline --> Matters To Be Discussed: The committee will discuss implementation of the ``Vaccines for Children Program''; the scope of the ``Vaccines for Children Program,'' including specific wording for hepatitis B, second dose Measles, Mumps, Rubella (MMR) and MMR catch-up, and influenza and pneumococcal vaccines for high-risk children; ``Vaccines for Children Program'': Other issues and statement; status of simplification of vaccine schedule; adolescent immunizations; Institute of Medicine report on vaccine safety, DTP and chronic encephalopathy, and other vaccines; proposed hepatitis A statement; hepatitis C; revised hepatitis B recommendation; revision of the varicella statement and status of application for licensure; revision of polio vaccine recommendation; BCG update; cost benefit analysis of rotavirus vaccines; National Vaccine Advisory Committee_adult immunization; an update on the National Vaccine Program; and an update on the Injury Compensation Program. Other matters of relevance among the committee's objectives may be discussed. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Agenda items are subject to change as priorities dictate. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=10 g=1 f=2 --> CONTACT PERSON FOR MORE INFORMATION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Gloria A. Kovach, Committee Management Specialist, CDC (1&hyph;B72), 1600 Clifton Road NE., Mailstop A20, Atlanta, Georgia 30333, telephone 404/639&hyph;3851. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: May 25, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> William H. Gimson, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Acting Associate Director for Policy Coordination, Centers for Disease Control and Prevention (CDC). <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;13376 Filed 6&hyph;1&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4163&hyph;18&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            